Epidemiological and Pathological Aspects of Cervical Cancer in Ivory Coast
Keywords:Cervix, Epidemiology, Squamous cell carcinoma, Ivory Coast
Cervical cancer is the most common and the leading cause of women death in developing countries.
Purpose: To specify the epidemiological and pathological characteristics of cervical cancers in Ivory Coast.
Material and methods: This was a retrospective and descriptive study on the cervical cancers histologically confirmed and identified from the registers for recording laboratory of pathological anatomy of Abidjan teaching hospital. The study period was 24 years (January 1984 to December 2007). The parameters analyzed were: frequency, age, socio-demographic status, macroscopic and histological aspects and the prognosis.
Results: The cervical cancer represented 78.78% (2064 cases) of gynecological cancers, 42.71% of woman cancer and 17.41% of all cancers. The average age was 48.36 years ranging from 2 to 88 years and a peak incidence between 45-54 years (29%). Multiparity was observed 57.04% (n = 231) and the low socioeconomic level was predominant (70.41%). Concerning pathological examination, the tumor lesions were predominantly budding (51.52%). Squamous cell carcinomas (92.88%) were the most frequent of histological types with 95.1% (n = 1823) of invasive carcinomas. The average age of patients with squamous cell carcinoma was 49 years with 41.5 years for intraepithelial carcinomas and 46.8 years for invasive carcinomas. At the prognosis, squamous cell carcinomas were diagnosed most often in stage pT2 (57.41%) and with extra-cervical represented 66.4% (n = 519).
Conclusion: Cervical cancer is the most common cancer in Ivory Coast taking into account male and female together. Its poor prognosis associated with late diagnosis should encourage the establishment of a cytology screening program.
N'Guessan K, Kouakou F, Praise V, et al. Cancer of the cervix: epidemiological aspects and management in the African environment. Mali Med 2009; XXIV(3): 27-30.
Philippe M, Damienne C. Cervical cancer, gynecological and obstetrical practice Masson 2005.
Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer Incidence. Mortality and Prevalence Worldwide. IARC Cancer Base No. 5 Version 2.0., Lyon: IARC Press 2004.
Thomas L. Evolution of radiotherapy in cervical cancers located. Lett Gynecol 2001; 260: 21-4.
Diomandé I, D'Horpock AF, Heroin P, et al. Evolution of cancer in Côte d'Ivoire. Ivory Coast Rev Med 1988; 75: 81-4.
Sangaret M, Kone N, Houphouet K, et al. Cervical cancer in Africa: Epidemiological aspects. Med J Ivory Coast 1986; 75: 112-8.
Toure P, Corre P, Diaby A. Cervical cancer in African environment at Dakar. A retrospective study of 411 cases observed at the Cancer Institute. Med Dakar 1981; 26: 59-70.
Muteganya D, Bigayi T, Bigirimana V, Sindayirwanza JB, Marerwa G. The cervical cancer at the University Hospital of Kamenge about 35 cases. Med Afr Noire 1999; 46(3): 153-6.
Ben Youssef R, Maalej M, Ben Abdallah M, et al. Cervical cancer in Tunisia. Clinical presentation and evolution during a period of 10 years. J Gynecol Obstet Biol Reprod 1987; 16: 63-7.
The cancer situation in France in 2010. www.e-cancers.fr/.../6035-la status-of-cancer-in-France-in-2010.pdf. Accessed on 03/04/2012.
Banza K, Kizonde J, Unga M, Muiach K, Kabila B, Kalenga MK. Cancer of the cervix: Problems in management. About 40 cases seen at the hospital in Lubumbashi. Lub Med 1999; 2.
Abboud J, Attieh E, Germanos A. Invasive cervical cancer. Treatment tailored to the available therapeutic means. J Gynecol Obstet Biol Reprod 1992; 21: 19-22.
Dargent D, Kouakou F, Cholmier M, Adeline P. Cervical cancer in women under 35 years of age: a new disease. Rev Fr Obstet Gynecol 1991; 86: 635-38.
Maiman M, Fruchter RG, Sedlis A, et al. Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women infected with human immunodeficiency virus. Gynecol Oncol 1998; 68: 233-39. http://dx.doi.org/10.1006/gyno.1998.4938
Moodley M, Moodley J, Kleinschmidt I. The invasive cervical cancer and human immunodeficiency virus (HIV): a perspective from South Africa. Int J Gynecol Cancer 2001; 11(3): 194-7. http://dx.doi.org/10.1046/j.1525-1438.2001.01022.x
Buga GA. Cervical cancer awareness and risk factors among female university students. East African Med J 1998; 75(7): 411-6.
Moscicki AB, Ellenberg JH, Vermund SH. Prevalence and risk for cervical human papillomavirus infection and squamous lesions in intaepithelial teen girls: impact of infection with human immunodefiency virus. Arch Ediat Adolesc Med 2000; 154: 127-34.
Raharisolo Vololonantenaina CR, Rabarijaona LP, Soares JL, et al. Assessment of cervical cancers diagnosed at the Pasteur Institute of Madagascar from 1992 to 2002. Arch Inst Pasteur Madagascar 2003; 69(1 & 2): 77-81.
Effi AB, N'Dah KJ, N'Guiessan AA, et al. Epidemiology and Pathology of carcinoma in Ivory Coast. Afr J Cancer 2012; 4: 41-7. http://dx.doi.org/10.1007/s12558-011-0189-2
Lellan Mc RMC, Dillon MB, Woodruff JD, Heatley GJ, Field AL, Osenshein BR. Long term follow our stage I cervical adenocarcinoma of treated fish by radical surgery. Gynecol Oncol 1994; 52(2): 253-9. http://dx.doi.org/10.1006/gyno.1994.1041
Kaufman RH, Korhonen MO, Strama T, Adam E, Kaplan A. Development of clear cell adenocarcinoma in off spring of exposed under observation. Obstet Gynecol 1982; 59: 68S-72S.